153 related articles for article (PubMed ID: 23389772)
1. GRO-α/CXCR2 system and ADAM17 correlated expression in Sjögren's syndrome.
Lisi S; Sisto M; Lofrumento DD; D'Amore M; De Lucro R; Ribatti D
Inflammation; 2013 Jun; 36(3):759-66. PubMed ID: 23389772
[TBL] [Abstract][Full Text] [Related]
2. New insights into ADAMs regulation of the GRO-α/CXCR2 system: focus on Sjögren's syndrome.
Sisto M; Lisi S
Int Rev Immunol; 2015; 34(6):486-99. PubMed ID: 25386842
[TBL] [Abstract][Full Text] [Related]
3. A potential role of the GRO-α/CXCR2 system in Sjögren's syndrome: regulatory effects of pro-inflammatory cytokines.
Lisi S; Sisto M; Lofrumento DD; D'Amore M; De Lucro R; Ribatti D
Histochem Cell Biol; 2013 Feb; 139(2):371-9. PubMed ID: 23052840
[TBL] [Abstract][Full Text] [Related]
4. Pro-inflammatory role of Anti-Ro/SSA autoantibodies through the activation of Furin-TACE-amphiregulin axis.
Lisi S; Sisto M; Lofrumento DD; Cucci L; Frassanito MA; Mitolo V; D'Amore M
J Autoimmun; 2010 Sep; 35(2):160-70. PubMed ID: 20673622
[TBL] [Abstract][Full Text] [Related]
5. Sjögren's syndrome autoantibodies provoke changes in gene expression profiles of inflammatory cytokines triggering a pathway involving TACE/NF-κB.
Lisi S; Sisto M; Lofrumento DD; D'Amore M
Lab Invest; 2012 Apr; 92(4):615-24. PubMed ID: 22157716
[TBL] [Abstract][Full Text] [Related]
6. Induction of TNF-alpha-converting enzyme-ectodomain shedding by pathogenic autoantibodies.
Sisto M; Lisi S; Lofrumento DD; Frassanito MA; Cucci L; D'Amore S; Mitolo V; D'Amore M
Int Immunol; 2009 Dec; 21(12):1341-9. PubMed ID: 19854762
[TBL] [Abstract][Full Text] [Related]
7. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies.
Sisto M; Lisi S; Lofrumento DD; Caprio S; Mitolo V; D'Amore M
Immunobiology; 2010 Nov; 215(11):874-83. PubMed ID: 20061048
[TBL] [Abstract][Full Text] [Related]
8. Regulation of CXCR2 expression and function by a disintegrin and metalloprotease-17 (ADAM17).
Mishra HK; Long C; Bahaie NS; Walcheck B
J Leukoc Biol; 2015 Mar; 97(3):447-54. PubMed ID: 25412626
[TBL] [Abstract][Full Text] [Related]
9. Expression of pro-inflammatory TACE-TNF-α-amphiregulin axis in Sjögren's syndrome salivary glands.
Sisto M; Lisi S; Lofrumento DD; Ingravallo G; Mitolo V; D'Amore M
Histochem Cell Biol; 2010 Oct; 134(4):345-53. PubMed ID: 20811902
[TBL] [Abstract][Full Text] [Related]
10. The metalloproteinase ADAM17 and the epidermal growth factor receptor (EGFR) signaling drive the inflammatory epithelial response in Sjögren's syndrome.
Sisto M; Lisi S; D'Amore M; Lofrumento DD
Clin Exp Med; 2015 May; 15(2):215-25. PubMed ID: 24664458
[TBL] [Abstract][Full Text] [Related]
11. Autoimmune epithelitis (Sjögren's syndrome); the impact of metabolic status of glandular epithelial cells on auto-immunogenicity.
Katsiougiannis S; Tenta R; Skopouli FN
J Autoimmun; 2019 Nov; 104():102335. PubMed ID: 31540861
[TBL] [Abstract][Full Text] [Related]
12. The salivary gland epithelial cells of patients with primary Sjögren's syndrome manifest significantly reduced responsiveness to 17β-estradiol.
Manoussakis MN; Tsinti M; Kapsogeorgou EK; Moutsopoulos HM
J Autoimmun; 2012 Aug; 39(1-2):64-8. PubMed ID: 22309821
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic dysregulation in salivary glands from patients with primary Sjögren's syndrome may be ascribed to infiltrating B cells.
Thabet Y; Le Dantec C; Ghedira I; Devauchelle V; Cornec D; Pers JO; Renaudineau Y
J Autoimmun; 2013 Mar; 41():175-81. PubMed ID: 23478041
[TBL] [Abstract][Full Text] [Related]
14. GRO-α and IL-8 enhance ovarian cancer metastatic potential via the CXCR2-mediated TAK1/NFκB signaling cascade.
Yung MM; Tang HW; Cai PC; Leung TH; Ngu SF; Chan KK; Xu D; Yang H; Ngan HY; Chan DW
Theranostics; 2018; 8(5):1270-1285. PubMed ID: 29507619
[TBL] [Abstract][Full Text] [Related]
15. B7-H4 deficiency in salivary gland of patients with primary Sjögren's syndrome impairs the regulatory effect on T cells.
Li X; Yu D; Yu N; Wang X; Li X; Harris DCH; Wang Y
Int J Rheum Dis; 2017 Apr; 20(4):474-480. PubMed ID: 28217953
[TBL] [Abstract][Full Text] [Related]
16. CD40 on salivary gland epithelial cells: high constitutive expression by cultured cells from Sjögren's syndrome patients indicating their intrinsic activation.
Dimitriou ID; Kapsogeorgou EK; Moutsopoulos HM; Manoussakis MN
Clin Exp Immunol; 2002 Feb; 127(2):386-92. PubMed ID: 11876766
[TBL] [Abstract][Full Text] [Related]
17. Pro-inflammatory cytokines enhance ERAD and ATF6α pathway activity in salivary glands of Sjögren's syndrome patients.
Barrera MJ; Aguilera S; Castro I; Cortés J; Bahamondes V; Quest AFG; Molina C; González S; Hermoso M; Urzúa U; Leyton C; González MJ
J Autoimmun; 2016 Dec; 75():68-81. PubMed ID: 27461470
[TBL] [Abstract][Full Text] [Related]
18. Effects of biological drug adalimumab on tumour necrosis factor-alpha-converting enzyme activation.
Lisi S; Sisto M
Immunol Cell Biol; 2010; 88(3):297-304. PubMed ID: 19949420
[TBL] [Abstract][Full Text] [Related]
19. Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB.
Sisto M; Lisi S; Lofrumento DD; D'Amore M; Frassanito MA; Ribatti D
Genes Immun; 2012 Jul; 13(5):411-20. PubMed ID: 22513453
[TBL] [Abstract][Full Text] [Related]
20. Epithelial CXCR3-B regulates chemokines bioavailability in normal, but not in Sjogren's syndrome, salivary glands.
Sfriso P; Oliviero F; Calabrese F; Miorin M; Facco M; Contri A; Cabrelle A; Baesso I; Cozzi F; Andretta M; Cassatella MA; Fiocco U; Todesco S; Konttinen YT; Punzi L; Agostini C
J Immunol; 2006 Feb; 176(4):2581-9. PubMed ID: 16456020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
